Company page
Synact Pharma Ab
Synact Pharma AB, trading under the ticker SYNACT, is a public company based in Sweden with a market capitalization of approximately 64.7 million USD. The company focuses on developing innovative therapies aimed at treating autoimmune diseases. Synact Pharma is committed to advancing its research and development efforts to improve patient outcomes.
- Ticker
- SYNACT:OMXSTO
- Asset type
- Stock
- Market cap
- $64.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK